<DOC>
	<DOCNO>NCT01574183</DOCNO>
	<brief_summary>Marijuana commonly use illicit drug , yet clinical trial evaluate pharmacotherapy treatment marijuana dependence . This study evaluate efficacy vilazodone reduce marijuana use marijuana-dependent adult . A contingency management intervention ( CM ) motivational enhancement therapy ( MET ) incorporate encourage study engagement retention , genomic DNA extract characterize subject accord polymorphisms gene potentially relevant activity vilazodone . It hypothesize vilazodone combine MET CM reduce percent marijuana-positive urine drug screen result marijuana-dependent individual compare placebo treatment combine MET CM .</brief_summary>
	<brief_title>Vilazodone Treatment Marijuana Dependence</brief_title>
	<detailed_description>The purpose study determine medication vilazodone effective help frequent marijuana smoker cut stop use marijuana . Vilazodone FDA approve treatment depression- study , vilazodone 's effect marijuana dependence investigate . Participation study take 10 visit period approximately two three month . The first visit screen visit determine participant eligible participate . After initial assessment visit , weekly visit take 30 minute , exception three therapy session take approximately 60-90 minute . The three therapy session focus participant 's marijuana use reason may stop cut use . After complete initial therapy session , participant randomly select receive study medication , either vilazodone placebo ( capsule contain active medication ) . Participants weekly study visit clinician . At study visit , ask fill form answer specific question concern substance use , anxiety symptom , feeling general . They provide urine sample check illegal drug abuse include marijuana drug . They also blood sample draw determine take medication direct .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Must meet DSMIV criterion marijuana dependence Must age 18 65 year old If female childbearing potential , must agree use acceptable method birth control duration trial . Cannabispositive urine drug screen screen Must consent random assignment Must able read provide inform consent Women pregnant , nursing , plan become pregnant course study Must history current psychotic disorder , bipolar disorder , eat disorder Must pose current suicidal homicidal risk Must evidence history serious medical disease Must require concomitant therapy psychotropic medication CYP3A4 inhibitor Must currently dependent substance , exception nicotine ; Patients , investigator 's opinion , would unable comply study procedure assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Marijuana</keyword>
	<keyword>Vilazodone</keyword>
	<keyword>Contingency management</keyword>
	<keyword>Motivational enhancement therapy</keyword>
</DOC>